Indeed, the ceRNAs identified in the prostate cancer model may also have an impact in other tumor settings; likewise, other lncRNA of ferritin pseudogenes may act in a similar way, which is why the measurement of lncRNA-FTH1-pseudogenes expression levels is desirable in those tumor models in which FTH1, iron balance, and oxidative stress appear to be involved. The gene discussed is FTH1; the disease is Familial prostate cancer.